The association of osteocalcin and adiponectin with glucose metabolism in nondiabetic postmenopausal women

Gynecologic and Obstetric Investigation

Volumn 77, Issue 4, 2014, Pages 255-260

  Caglar, Gamze S ^a   Ozdemir, Elif D ^a   Kiseli, Mine ^a   Demirtas, Selda ^a   Cengiz, Sevim D ^a  

^a UFUK UNIVERSITY   (Turkey)

Author keywords

Adiponectin; Fasting insulin; Fasting plasma glucose; Metabolic syndrome; Nondiabetic postmenopausal women; Osteocalcin; Serum lipids

Indexed keywords

ADIPONECTIN; GLUCOSE; INSULIN; LIPID; OSTEOCALCIN; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL;

ADULT; ARTICLE; BODY MASS; CARDIOMETABOLIC RISK; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; POSTMENOPAUSE; PRIORITY JOURNAL; QUANTITATIVE INSULIN SENSITIVITY CHECK INDEX; AGED; BLOOD; CROSS-SECTIONAL STUDY; METABOLISM; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR;

ADIPONECTIN; AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INSULIN RESISTANCE; METABOLIC SYNDROME X; MIDDLE AGED; OSTEOCALCIN; POSTMENOPAUSE; RISK FACTORS; ROC CURVE;

EID: 84900900053     PISSN: 03787346     EISSN: 1423002X     Source Type: Journal    
DOI: 10.1159/000358826     Document Type: Article

References (35)

1. Confavreux CB, Levine RL, Karsenty G: A paradigm of integrative physiology, the crosstalk between bone and energy metabolisms. Mol Cell Endocrinol 2009; 310:21-29.
2. Confavreux CB: Interactions between bone tissue and energy metabolism. Joint Bone Spine 2010; 77:287-289.
3. Lee NK, Sowa H, Hinoi E, et al: Endocrine regulation of energy metabolism by the skeleton. Cell 2007; 130:456-469. (Pubitemid 47208519)
4. Ferron M, Hinoi E, Karsenty G, Ducy P: Os-teocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc Natl Acad Sci USA 2008; 105: 5266-5270. (Pubitemid 351738545)
5. Clemens TL, Karsenty G: The osteoblast: an insulin target cell controlling glucose homeo-stasis. J Bone Miner Res 2011; 26:677-680.
6. Pittas AG, Harris SS, Eliades M, Stark P, Daw-son-Hughes B: Association between serum os-teocalcin and markers of metabolic phenotype. J Clin Endo crinol Metab 2009; 94: 827-832.
7. Lee NK, Karsenty G: Reciprocal regulation of bone and energy metabolism. J Musculoskelet Neuronal Interact 2008; 8:351.
8. Martin TJ: A skeleton key to metabolism. Nat Med 2007; 13:1021-1023. (Pubitemid 47517496)
9. Yeap BB, Chubb SA, Flicker L, et al: Reduced serum total osteocalcin is associated with metabolic syndrome in older men via waist circumference, hyperglycemia, and triglyceride levels. Eur J Endocrinol 2010; 163:265-272.
10. Zhou M, Ma X, Li H, et al: Serum osteocalcin concentrations in relation to glucose and lipid metabolism in Chinese individuals. Eur J En-docrinol 2009; 161:723-729.
11. Kindblom JM, Ohlsson C, Ljunggren O, et al: Plasma osteocalcin is inversely related to fat mass and plasma glucose in elderly Swedish men. J Bone Miner Res 2009; 24:785-791.
12. Fernández-Real JM, Izquierdo M, Ortega F, et al: The relationship of serum osteocalcin concentration to insulin secretion, sensitivity, and disposal with hypocaloric diet and resistance training. J Clin Endocrinol Metab 2009; 94:237-245.
13. Im JA, Yu BP, Jeon JY, Kim SH: Relationship between osteocalcin and glucose metabolism in postmenopausal women. Clin Chim Acta 2008; 396:66-69.
14. Wah Ng K: Regulation of glucose metabolism and the skeleton. Clin Endocrinol 2011; 75: 147-155.
15. Matthews DR, Hosker JP, Rudenski AS, Nay-lor BA, Treacher DF, Turner RC: Homeosta-sis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabeto-logia 1985; 28:412-419. (Pubitemid 15018832)
16. Katz A, Nambi SS, Mather K, et al: Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000; 85:2402-2410. (Pubitemid 32269192)
17. Hedblad B, Nilsson P, Engström G, Berglund G, Janzon L: Insulin resistance in non-diabetic subjects is associated with increased incidence of myocardial infarction and death. Di-abet Med 2002; 19:470-475. (Pubitemid 34639157)
18. Hrebícek J, Janout V, Malincíková J, Horáková D, Cízek L: Detection of insulin resistance by simple quantitative insulin sensitivity check index QUICKI for epidemiological assessment and prevention. J Clin Endocrinol Metab 2002; 87:144-147. (Pubitemid 34084683)
19. Grundy SM, Cleeman JI, Daniels SR, et al; American Heart Association; National Heart, Lung, and Blood Institute: Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112:2735-2752. (Pubitemid 41532612)
20. Lieben L, Callewaert F, Bouillon R: Bone and metabolism: a complex crosstalk. Horm Res 2009; 71:134-138.
21. Third Report of the National Cholesterol Education Program (NCEP): Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Circulation 2002; 106: 3143-3421.
22. Winhofer Y, Handisurya A, Tura A, et al: Os-teocalcin is related to enhanced insulin secretion in gestational diabetes mellitus. Diabetes Care 2010;33:139-143.
23. Hwang YC, Jeong IK, Ahn KJ, Chung HY: Circulating osteocalcin level is associated with improved glucose tolerance, insulin secretion and sensitivity independent of the plasma adiponectin level. Osteoporos Int 2011;23:1337-1342.
24. Kanazawa I, Yamaguchi T, Tada Y, et al: Serum osteocalcin level is positively associated with insulin sensitivity and secretion in patients with type 2 diabetes. Bone 2011; 48:720-725.
25. García-Martín A, Cortés-Berdonces M, Luque-Fernández I, Rozas-Moreno P, Quesada-Char-neco M, Muñoz-Torres M: Osteocalcin as a marker of metabolic risk in healthy postmeno-pausal women. Menopause 2011; 18: 537-541.
26. Matsuzawa Y, Funahashi T, Nakamura T: The concept of metabolic syndrome: contribution of visceral fat accumulation and its molecular mechanism. J Atheroscler Thromb 2011;18: 629-639.
27. Yang Z, Yang X, Xu J, Sun Y, Shi Y, Fang S: Association between adiponectin receptor 1 gene polymorphism and insulin resistance in Chinese patients with polycystic ovary syndrome. Gynecol Obstet Invest 2014; 77:45-49.
28. Compston JE, Flahive J, Hosmer DW, et al: Relationship of weight, height and body mass index with fracture risk at different sites in postmenopausal women: the Global Longitudinal Study of Osteoporosis in Women (GLOW). J Bone Miner Res 2014; 29:487-493.
29. Ryo M, Nakamura T, Kihara S, et al: Adipo-nectin as a biomarker of the metabolic syndrome. Circ J 2004; 68:975-981.
30. Saleem U, Mosley TH Jr, Kullo IJ: Serum os-teocalcin is associated with measures of insulin resistance, adipokine levels, and the presence of metabolic syndrome. Arterioscler Thromb Vasc Biol 2010; 30:1474-1478.
31. Park KK, Kim SJ, Moon ES: Association between bone mineral density and metabolic syndrome in postmenopausal Korean women. Gynecol Obstet Invest 2010; 69:145-152.
32. Matsubara M, Maruoka S, Katayose S: Decreased plasma adiponectin concentrations in women with dyslipidemia. J Clin Endocrinol Metab 2002; 87:2764-2769. (Pubitemid 34655342)
33. Shea MK, Gundberg CM, Meigs JB, et al: γ-Carboxylation of osteocalcin and insulin resistance in older men and women. Am J Clin Nutr 2009; 90:1230-1235.
34. Lu C, Ivaska KK, Alen M, et al: Serum osteo-calcin is not associated with glucose but is inversely associated with leptin across generations of nondiabetic women. J Clin Endocri-nol Metab 2012; 97:4106-4114.
35. Gundberg CM, Lian JB, Booth SL: Vitamin K-dependent carboxylation of osteocalcin: friend or foe? Adv Nutr 2012; 3: 149-157.